Peter Nilsson
Peter Nilsson explains to Peter Goodwin his clear recommendation that doctors should manage hyperglycaemia aggressively in patients with Type II diabetes following his discussions in Milan about the meta-analysis of five big studies recently published in The Lancet which confirms a reduction of cardiovascular events. He also discusses Early Vascular Aging (EVA) and what to do about it, namely to use: ADAM: Aggressive Decrease of Atherosclerosis Modifiers.
Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.